| Title | Date | PubMed ID |
|---|
| Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma. | 2017 Jul 17 | 28714949 |
| Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma. | 2017 Feb 21 | 28099905 |
| Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. | 2016 Apr | 26683595 |
| Regulation of Aspartyl-(Asparaginyl)-β-Hydroxylase Protein Expression and Function by Phosphorylation in Hepatocellular Carcinoma Cells. | 2015 Apr 1 | 26029741 |
| Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. | 2015 Mar 3 | 25629522 |
| Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype. | 2015 Jan 20 | 25483102 |
| The aspartyl (asparaginyl) beta-hydroxylase in carcinomas. | 2015 Jan 1 | 25553486 |
| Inhibition of human natural killer cell functional activity by human aspartyl β-hydroxylase. | 2014 Dec | 25281391 |
| Single-chain variable fragment antibody against human aspartyl/asparaginyl beta-hydroxylase expressed in recombinant Escherichia coli. | 2011 Feb | 21466288 |
| Asparaginyl beta-hydroxylation of proteins containing ankyrin repeat domains influences their stability and function. | 2009 Oct 2 | 19646994 |